Biotech · Private company
Quetzal Therapeutics
Track this companyFree. Adds Quetzal Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- IV arsenic trioxide (ATO) + ATRAPhase 3 · Acute Promyelocytic Leukemia (APL)ClinicalTrials.gov · fetched Nov 12, 2026
- QTX-2101 + ATRAPhase 3 · Acute Promyelocytic Leukemia (APL)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic LeukemiaPHASE3 · RECRUITING · started Jun 8, 2026ClinicalTrials.gov NCT07504458 · fetched Nov 12, 2026